Add-on Acquisition • Life Science

Rafa Laboratories Acquires ExCEEd

On August 1, 2022, Rafa Laboratories acquired life science company ExCEEd

Acquisition Context

This is Rafa Laboratories’ 1st transaction in the Life Science sector.
This is Rafa Laboratories’ 1st transaction in Czech Republic.

Explore All 3113 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	August 1, 2022
Target	ExCEEd
Sector	Life Science
Buyer(s)	Rafa Laboratories
Deal Type	Add-on Acquisition

Target Company

ExCEEd

Prague, Czech Republic

ExCEEd is focused on innovative treatments for rare diseases and has extensive experience in launching innovative medicines in this field. The portfolio of ExCEEd Orphan includes products in therapeutic areas of hematology, neurology, immunology, and metabolic diseases. ExCEEd was founded in 2018 and is based in Prague, Czech Republic.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Rafa Laboratories

Jerusalem, Israel

Category	Company
Founded	1937
Sector	Healthcare Services

DESCRIPTION

Rafa Laboratories is a provider of an emergency solutions – medical countermeasures, supplying auto-injectors for government agencies, military forces and civilian populations. Rafa Laboratories was founded in 1937 and is based in Jerusalem, Israel.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Czech Republic	1 of 1
Year: 2022	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Czech Republic M&A - 2022 M&A